Therefore, we hypothesized that an insulin-resistant state in individuals with obesity may be compensated by an increase in β-cell mass, but that a decrease in serotonin production or action may disrupt this compensatory mechanism, leading to sudden β-cell dysfunction followed by DK/DKA development in persons with KPD. Here, INS is linked to obesity disorder.